The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

13 Mar 2009 07:00

Cubus Lux plc ("Cubus Lux" or the "Company") Issue of Equity

Cubus Lux, the Croatia-focused leisure resort operator and developer, announces that it has agreed to issue 3,211,756 ordinary shares of 10p each in the capital of the Company ("Shares") at a price of 40p each. Application has been made for admission of these Shares to AIM, and this is expected to become effective on 18 March 2009. The net proceeds of the issue of equity will be applied towards reducing certain bank borrowings of the Company associated with the marina in Sutomiscica (with a commensurate interest charge reduction) and for general working capital purposes.

Of these Shares, 1,188,878 these Shares are to be issued to Dodge Private Equity Limited, a company in which Gerhard Huber (the Chairman of Cubus Lux) is interested, and a further 1,188,878 are to be issued to Phoenix Holdings Limited, a company in which Christian Kaiser (a director of Cubus Lux) is interested.

Accordingly, the issue of these 2,377,756 Shares constitutes a related party transaction (the "Related Party Placing") as defined in the AIM Rules for Companies. Where a company whose shares are quoted on AIM enters into such a transaction, the requirement is for those directors of the company who are independent of the transaction to consider, after consultation with the company's nominated adviser, whether the terms of the transaction are fair and reasonable insofar as the company's shareholders are concerned.

The independent directors (being all of the directors with the exception of Gerhard Huber and Christian Kaiser), having consulted with Dowgate Capital Advisers Limited, consider that the terms of the Related Party Placing are fair and reasonable insofar as the shareholders of the Company are concerned.

Following this issue of shares, the shareholdings of the directors are asfollows: Number of Percentage of Options ordinary ordinary share shares capital in issue Gerhard Huber 3,130,861 17.51% 200,000Christian Kaiser 2,251,604 12.60% 100,000Michael Janssen 460,688 2.58% 100,000Leon Nahon 61,466 0.34% 100,000Steve McCann 30,000 0.17% 130,000Eli Abramovich 24,000 0.13% 100,000Francisco Alvarez - -% -

Following this issue of shares, the shareholdings of significant shareholders (ie holders of more than 3 per cent.) are as follows:

Number of Percentage of ordinary ordinary share shares capital in issue Milan Kotur 1,297,754 7.26%Allveritas Inverciones SA 1,081,428 6.05%Kling GmbH 1,140,000 6.38%Xavier Azalbert 574,467 3.21%

Following this issue of shares, and in conformity with the Financial Services Authority's Disclosure and Transparency Rules, Cubus Lux gives notice that its voting capital consists of:

Ordinary Shares Nominal Value Ordinary Shares held in Treasury 17,876,122 10p £1,787,612.20 -

As Cubus Lux does not hold any ordinary shares in Treasury, its total number of voting rights equals its capital.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Cubus Lux under the FSA's Disclosure and Transparency Rules.

For further information please see www.cubuslux.com or contact:

Steve McCannCubus Lux plc+385 (0)99 214 9636Simon Sacerdoti/Liam Murray, Nominated AdviserDowgate Capital Advisers Limited+44 (0)20 7492 4777Claire Louise Noyce/Stephen Austin, BrokerHybridan LLP+44 (0)20 3159 5085Pam SpoonerCity Road Communications+44 (0) 20 7248 8010+44 (0)7858 477 747

vendor
Date   Source Headline
23rd Dec 20227:00 amRNSTR-1: Standard notification of major holdings
23rd Dec 20227:00 amRNSCellular Goods Annual Results
23rd Nov 20226:16 pmRNSTR-1: Standard notification of major holdings
2nd Nov 202210:34 amRNSTR-1: Standard notification of major holdings
24th Oct 20227:00 amRNSProducts launch on Debenhams.com
20th Oct 20227:00 amRNSLaunch of gift set collection for festive season
26th Sep 20227:00 amRNSProposed purchase of Cannaray Brands and Love CBD
23rd Sep 20225:49 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20225:47 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20225:42 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20227:00 amRNSCellular Goods now shipping products to the USA
23rd Sep 20227:00 amRNSCellular Goods now shipping products to the USA
21st Sep 20222:06 pmRNSSecond Price Monitoring Extn
21st Sep 20222:00 pmRNSPrice Monitoring Extension
21st Sep 20227:00 amRNSLaunch of three new skincare products
6th Sep 20227:00 amRNSPublication of new white paper
17th Aug 20227:00 amRNSGrant of Share Options
16th Aug 20227:00 amRNSAppointment of new Chief Financial Officer
5th Aug 20224:40 pmRNSSecond Price Monitoring Extn
5th Aug 20224:35 pmRNSPrice Monitoring Extension
4th Aug 20229:05 amRNSSecond Price Monitoring Extn
4th Aug 20229:00 amRNSPrice Monitoring Extension
3rd Aug 20224:41 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
3rd Aug 20229:05 amRNSSecond Price Monitoring Extn
3rd Aug 20229:00 amRNSPrice Monitoring Extension
2nd Aug 20224:40 pmRNSSecond Price Monitoring Extn
2nd Aug 20224:35 pmRNSPrice Monitoring Extension
2nd Aug 202211:05 amRNSSecond Price Monitoring Extn
2nd Aug 202211:00 amRNSPrice Monitoring Extension
1st Aug 20222:00 pmRNSPrice Monitoring Extension
13th Jul 20227:00 amRNSUpdate on marketing initiatives and YouGov survey
11th Jul 20227:00 amRNSLaunch of minis
20th Jun 20227:00 amRNSLaunch of CBG and CBD petition
30th May 20227:00 amRNSInterim results
20th May 20227:00 amRNSTR-1: Standard notification of major holdings
20th May 20227:00 amRNSTR-1: Standard notification of major holdings
16th May 20222:05 pmRNSSecond Price Monitoring Extn
16th May 20222:00 pmRNSPrice Monitoring Extension
12th May 20227:00 amRNSBoard changes
28th Apr 20227:00 amRNSInvestor presentation
28th Apr 20227:00 amRNSFirst patent application filed
22nd Apr 20226:04 pmRNSUpdate on ingestibles product range
22nd Apr 20227:00 amRNSWhite paper on lab-produced cannabinoids
13th Apr 20227:00 amRNSUpdate on ingestibles product range
11th Apr 20227:00 amRNSUpdate on ingestibles products
7th Apr 202210:24 amRNSTR-1: Standard notification of major holdings
1st Apr 20222:05 pmRNSSecond Price Monitoring Extn
1st Apr 20222:00 pmRNSPrice Monitoring Extension
28th Mar 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.